Vaximm Strengthens Leadership with Appointment of Sébastien Wieckowski as Chief Scientific Officer Vaximm's recent appointment of Sébastien Wieckowski, PhD, as CSO exemplifies its commitment to advancing its pioneering oral immunotherapy platform aimed at cancer treatment.

Vaximm Strengthens Leadership with Appointment of Sébastien Wieckowski as Chief Scientific Officer #USA #Bellevue #VXM01 #Vaximm #Sébastien_Wieckowski